Longer-term response to SARS-CoV-2 vaccine in MPN patients: Role of ruxolitinib and disease severity.

ABSTRACT:

SUBMITTER: Auteri G 

PROVIDER: S-EPMC8893928 | biostudies-literature | 2022 May

REPOSITORIES: biostudies-literature